TYPE 2 DIABETES MELLITUS – AN AUTOIMMUNE DISEASE?

Cover Page


Cite item

Full Text

Abstract

In recent years, the association of type 2 diabetes mellitus (DM) to autoimmune diseases has been discussed. Participation of innate immunity in the development of inflammation in obesity and insulin resistance, which determine the development of type 2 DM is well known. These changes, along with gluco- and lipotoxicity, lead to the destruction of the pancreatic β cells, emergence of autoantigens and development both humoral and cell type autoimmune reactions. The effectiveness of drugs used in the treatment of autoimmune diseases also leads some authors to the conclusion that type 2 diabetes can be referred to autoimmune diseases. However, most researchers believe that the presence of an autoimmune component is a side effect of inflammation and do not consider type 2 diabetes as an autoimmune disease.

Alternatively, autoimmune reactions may take part in the pathogenesis of type 2 diabetes because: a viral infection contributes to the development of antiviral immunity, however, in the presence of insulin-cross-reactive antigens, an autoimmune reaction is observed. Most patients with uncompromised immune system, the clone of auto-aggressive cells sensitized to insulin is destroyed. In a small percentage of patients with impaired immune system, insulin-sensitized lymphocytes do not die that leads to destruction of pancreatic islet cells and development of type 1 diabetes. In other patients, on the one hand, the immune system is also unable to remove the cell clone exerting signs of autoaggression, but it tries to suppress this effect by blocking insulin receptors on immunocompetent cells. This maneuver succeeds, and suppression is reversible. However, insulin receptors are abundant not only on sensitized lymphocytes, but also on liver cells, muscles, and adipose tissue. The effect of blocking insulin receptors in insulin-sensitive tissues contributes to the development of primary insulin resistance, which precedes and contributes to the development of obesity. Subsequently, excessive intake of dietary fats results in obesity progression, so that the entire cascade of inflammatory reactions is involved in the pathological process. This, in turn, contributes to the formation of secondary insulin resistance, which accounts for the development of type 2 diabetes and cardiovascular diseases and so on.

Type 2 diabetes does not belong to autoimmune diseases, but suppressed autoimmune reactions with respect to insulin play a role in the development of insulin resistance.

About the authors

N. S. Asfandiyarova

Ryazan State I. Pavlov Medical University

Author for correspondence.
Email: n.asfandiyarova2010@yandex.ru

Asfandiyarova Nailya S., PhD, MD (Medicine), Senior Research Assosiate, Assosiate Professor

390026, Ryazan, Visokovoltnaya str., 9. Phone: 7 (4912) 98-40-67

Russian Federation

References

  1. Асфандиярова Н.С. Гетерогенность сахарного диабета 2 типа: клиническая характеристика 4 подтипов // Терапевтический архив, 2011. Т. 83, № 10. С. 27-31.
  2. Асфандиярова Н.С., Низов А.А., Журавлева Н.С., Колдынская Э.И., Гиривенко А.И. Нестероидные противовоспалительные средства в лечении остеоартроза у больных сахарным диабетом 2 типа // Актуальные проблемы гуманитарных и естественных наук, 2013. № 12. С. 330-335.
  3. Асфандиярова Н.С., Шатров В.В., Гарипов Г.К. Сенсибилизация лимфоцитов к антигенам вирусов семейства Paramyxoviridae при сахарном диабете // Проблемы эндокринологии, 2006. Т. 52, № 6. С. 18-21.
  4. Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эндокринология: учебник. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2014. 442 с.
  5. Драенкова Ф.Р., Пустынкина Л.С., Лесовой А.Е. Динамика и тенденции первичной инвалидности взрослого раселения Рязанской области // Наука молодых, 2013. № 4. С. 117-121.
  6. Дубинина И.И., Урясьев О.М., Карапыш Т.В. Оценка качества жизни и корреляции углеводного обмена, гормонального спектра у больных сахарным диабетом 2 типа с первичным гипотиреозом, осложненным дистальной нейропатией // Российский медико-биологический вестник им. И.П. Павлова, 2011. № 4, С. 99-102.
  7. Самойлова Ю.Г., Новоселова М.В., Жукова Н.Г., Тонких О.С. Анализ роли нейроспецифических белков в диагностике когнитивной дисфункции у пациентов с сахарным диабетом 1 типа // Сахарный диабет, 2014. № 2. С. 83-90.
  8. Шварц В.Я. Воспаление жировой ткани (часть 1). Морфологические и функциональные проявления // Проблемы эндокринологии, 2009. Т. 5, № 4. С. 44-49.
  9. Шварц В.Я. Воспаление жировой ткани (часть 2). Патогенетическая роль при сахарном диабете 2 типа // Проблемы эндокринологии, 2009. Т. 55, № 5. С. 43-48.
  10. Шварц В.Я. Воспаление жировой ткани (часть 4). Ожирение – новое инфекционное заболевание? (обзор литературы) // Проблемы эндокринологии, 2011. Т. 57, № 5. С. 63-71.
  11. Asfandiyarova N.S. Cell-mediated immunity to insulin: A new criterion for differentiation of type 2 diabetes mellitus? Med. Hypoth., 2012, Vol. 78, pp. 402-406.
  12. Brooks-Worrell B., Narla R., Palmer J.P. Islet autoimmunity in phenotypic type 2 diabetes patients. Diabetes Obes. Metab., 2013, Vol. 15, no. 3, pp. 37-40.
  13. Brooks-Worrell B.M., Reichow J.L., Goel A., Ismail H., Palmer J.P. Identification of autoantibody-negative autoimmune type 2 diabetic patients. Diabetes Care., 2011, Vol. 34, no. 1, pp. 168-173.
  14. Buzzetti R., Spoletini M., Zampetti S., Campagna G., Marandola L., Panimolle F., Dotta F., Tiberti C., NIRAD Study Group (NIRAD 8). Tyrosine phosphatase-related islet antigen 2 (256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes. Diabetes Care, 2015, Vol. 38, no. 3, pp. 513-520.
  15. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med., 2005, Vol. 11, pp. 183-190.
  16. Chang X., Xiaoquan R., Jixin Z. Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation (Review article). J. Diab. Res., 2017, Vol. 2017, 6494795. doi: 10.1155/2017/6494795.
  17. Cho K.W., Morris D.L., DelProposto J.L., Geletka L., Zamarron B., Martinez-Santibanez G., Meyer K.A., Singer K., O’Rourke R.W., Lumeng C.N. An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesity-induced inflammation. Cell Rep., 2014, Vol. 9, no. 2, pp. 605–617.
  18. Dedov I., Shestakova M., Benedetti M.M., Simon D., Pakhomov I., Galstyan G. Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study). Diabetes Res. Clin. Pract., 2016, Vol. 115, pp. 90-95.
  19. Ehses J.A., Perren A., Eppler E., Ribaux P., Pospisilik J.A., Maor-Cahn R., Gueripel X., Ellingsgaard H., Schneider M.K., Biollaz G., Fontana A., Reinecke M., Homo-Delarche F., Donath M.Y. Increased number of isletassociated macrophages in type 2 diabetes. Diabetes, 2007, Vol. 56, no. 9, pp. 2356-2370.
  20. Guzmán-Flores J.M., López-Briones S. Células de la inmunidad innata y adaptativa en la diabetes mellitus tipo 2 y obesidad. [Cells of the innate and adaptive immunity in type 2 diabetes mellitus and obesity (Review)]. Gac. Med. Mex., 2012, Vol. 148, no. 4, pp. 381-389.
  21. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest., 1995, Vol. 95, pp. 2409-2415.
  22. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 1993, Vol. 259, pp. 87-91.
  23. International Diabetes Federation. IDF Diabetes Atlas. Brussels: IDF, 2017, 8th ed.
  24. Itani S.I., Ruderman N.B., Schmieder F., Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes, 2002, Vol. 51, pp. 2005–2011.
  25. Itariu B.K., Stulnig T.M. Autoimmune aspects of type 2 Diabetes Mellitus – a mini-review. Gerontology, 2014, Vol. 60, pp. 189-196.
  26. Jagannathan-Bogdan M., McDonnell M.E., Shin H., Rehman Q., Hasturk H., Apovian C.M., Nikolajczyk B.S. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J. Immunol., 2011, Vol. 186, no. 2, pp. 1162-1172.
  27. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes (Review). Nature, 2006, Vol. 444, no. 7121, pp. 840-846.
  28. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., Fischer-Posovszky P., Barth T.F., Dragun D., Skurk T., Hauner H., Blüher M., Unger T., Wolf A.M., Knippschild U., Hombach V., Marx N. T-lymphocyte infiltration in visceral adipose tissue a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscl. Thromb. Vasc. Biol., 2008, Vol. 28, pp. 1304-1310.
  29. Kohlgruber A., Lynch L. Adipose tissue inflammation in the pathogenesis of type 2 diabetes. Curr. Diab. Rep., 2015, Vol. 15, no. 11, 92. doi: 10.1007/s11892-015-0670-x.
  30. MacCuish A.C., Jordan J., Campbell C.J., Duncan L.J.P., Irvine W.J. Cell-mediated immunity in diabetes mellitus; lymphocyte transformation by insulin and insulin fragments in insulin-treated and newly-diagnosed diabetes. Diabetes, 1975, Vol. 24, no. 1, pp. 36-43.
  31. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metabolism, 2013, Vol. 17, no. 6, pp. 851-859.
  32. Morris D.L., Cho K.W., Delproposto J.L, Oatmen K.E., Geletka L.M., Martinez-Santibanez G., Singer K., Lumeng C.N. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes, 2013, Vol. 62, no. 8, pp. 2762-2772.
  33. Nishimura S., Manabe I., Nagasaki M. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med., 2009, Vol. 15, pp. 914-920.
  34. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol., 2011, Vol. 11, no. 2, pp. 85-97.
  35. Piatkiewicz P., Hajduk J.L., Chow K.L., Kowrach M., Kuszyk J.C. Autoimmunity markers in patients with type 2 diabetes. J. Clin. Diabetes Pract., 2016, Vol. 1, 107. doi: 10.4172/jcdp.1000107.
  36. Pietropaolo M., Barinas-Mitchell E., Pietropaolo S.L., Kuller L.H., Trucco M. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes, 2000, Vol. 49, no. 1, pp. 32-38.
  37. Raphael I., Nalawade S., Eagar T.N., Forsthuber T.G. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Review Article. Cytokine, 2015, Vol. 74, no. 1, pp. 5-17.
  38. Richardson S.J., Willcox A., Bone A.J., Foulis A.K., Morgan N.G. Islet-associated macrophages in type 2 diabetes. Diabetologia, 2009, Vol. 52, no. 8, pp. 1686-1688.
  39. Sabio G., Das M., Mora A., Zhang Z., Jun J.Y., Ko H.J., Barrett T., Kim J.K., Davis R.J. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science, 2008, Vol. 322, pp. 1539-1543.
  40. Shirakawa K., Yan X., Shinmura K., Endo J., Kataoka M., Katsumata Y., Yamamoto T., Anzai A., Isobe S., Yoshida N., Itoh H., Manabe I., Sekai M., Hamazaki Y., Fukuda K., Minato N., Sano M. Obesity accelerates T cell senescence in murine visceral adipose tissue. J. Clin. Invest. 2016, Vol. 126, no. 12, pp. 4626-4639.
  41. Shu C.J., Benoist C., Mathis D. The immune system’s involvement in obesity-driven type 2 diabetes. Semin. Immunol., 2012, Vol. 24, no. 6, pp. 436-442.
  42. Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., Grivennikov S., WynshawBoris A., Scadeng M., Olefsky J.M., Karin M. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab., 2007, Vol. 6, pp. 386-397.
  43. Strissel K.J., DeFuria J., Shaul M.E., Bennett G., Greenberg A.S., Obin M.S. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring), 2010, Vol. 18, no. 10, pp. 1918-1925.
  44. Tittanen M. Immune response to insulin and changes in the gut immune system in children with or at risk for type 1 diabetes [dissertation]. Helsinki: University of Helsinki, 2006.
  45. Tsai S., Clemente-Casares X., Revelo X.S., Winer Sh., Winer D.A. Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases? Diabetes, 2015, Vol. 64, no. 6, pp. 1886-1897.
  46. Tuncman G., Hirosumi J., Solinas G., Chang L., Karin M., Hotamisligil G.S. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA, 2006, Vol. 103, pp. 10741-10746.
  47. Velloso L.A., Eizirik D.L., Cnop M. Type 2 diabetes mellitus – an autoimmune disease? Nat. Rev. Endocrinol. 2013, Vol. 9, pp. 750-755.
  48. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA, 1999, Vol. 282, pp. 2131-2135.
  49. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., Tsui H., Wu P., Davidson M.G., Alonso M.N., Leong H.X., Glassford A., Caimol M., Kenkel J.A., Tedder T.F., McLaughlin T., Miklos D.B., Dosch H.M., Engleman E.G. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med., 2011, Vol. 17, no. 5, pp. 610-617.
  50. Witebsky E., Rose N.R., Terplan K., Paine J.R. Egan R.W. Chronic thyroiditis and autoimmunization. JAMA, 1957, Vol. 164, pp. 1439-1447.
  51. Yang H., Youm Y.H., Vandanmagsar B., Ravussin A., Gimble J.M., Greenway F., Stephens J.M., Mynatt R.L., Dixit V.D. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J. Immunol., 2010, Vol. 185, no. 3, pp. 1836-1845.
  52. Zhang C., Xiao C., Wang P., Xu W., Zhang A., Li Q., Xu X. The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Hum. Immunol., 2014, Vol. 75, no. 4, pp. 289-296.
  53. Zúñiga L.A., Shen W.J., Joyce-Shaikh B., Pyatnova E.A., Richards A.G., Thom C., Andrade S.M., Cua D.J., Kraemer F.B., Butcher E.C. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J. Immunol., 2010, Vol. 185, no. 11, pp. 6947-6959.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Asfandiyarova N.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies